Sweden’s Smoke-Free Success: Lessons on Blurring the Lines

Molly Ogbodum

Across the world, the dialogue about tobacco control is shifting away from treating all nicotine use as a single, uniform risk. Sweden exemplifies this change, having reduced its smoking prevalence to 5.4 percent and nearing the internationally recognized 5 percent smoke‑free target. From 2012 to 2024, the country’s smoking rate fell by more than 54 percent—faster than any other EU nation.

This achievement shows that an approach that recognises and differentiates between nicotine delivery systems can produce rapid results. Sweden’s success was not driven by product availability alone but by a willingness to acknowledge risk differences, communicate scientific evidence plainly, and prioritise realistic public‑health outcomes.

Central to understanding Tobacco Harm Reduction (THR) is the need to dispel the myth that all nicotine products pose identical dangers. The scientific evidence emphasises risk differentiation. The primary health hazard of tobacco use comes from the toxic substances produced by burning tobacco. Nicotine itself is not the main cause of smoking‑related illnesses; the danger lies in the smoke produced by combustion.

A landmark report by the Royal College of Physicians, “Nicotine Without Smoke,” concluded that the health risks associated with long‑term e‑cigarette use are unlikely to exceed 5 percent of those of traditional smoking. Independent reviews by Public Health England have confirmed these findings, establishing that while non‑combustible, reduced‑risk alternatives are not entirely risk‑free, they are considerably safer than smoking conventional cigarettes.

Nevertheless, a significant misconception persists in public discussions that treat all nicotine delivery systems as an identical threat. When awareness campaigns fail to distinguish between traditional tobacco products and reduced‑risk alternatives, they inadvertently deny adult smokers a realistic exit from combustible tobacco. This information gap is especially evident in Nigeria, where smoking prevalence remains a major challenge.

Although products such as nicotine pouches and vaping devices are increasingly available, they circulate without standardised public‑health guidance or accurate consumer information due to the absence of formal education. This creates an environment in which adult smokers seeking to quit traditional cigarettes rely on unsafe information or myths to understand their options.

Public‑health outcomes are fundamentally shaped by how evidence is interpreted and communicated to the public. Nigeria risks failing to engage with the evolving global scientific debate. In more than a decade, advanced smoke‑free nations achieved success because alternative nicotine products were made accessible, affordable, and socially acceptable based on clearly communicated evidence, with Sweden serving as a core case study.

Moving forward, a strong focus on education and the dissemination of accurate information is essential. The middle ground of tobacco control—where evidence‑based harm reduction occurs—is where the greatest gains in population health are achieved. By prioritising THR awareness, we can dismantle long‑standing myths and ensure that adult smokers receive clear, accurate, and correct information necessary to transition away from the most harmful forms of tobacco use.

Ogbodum is a Public Health Advocate